Related Experiment Video
Updated: May 23, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
[Kidney injury biomarkers]
Yann Gueguen1, Caroline Rouas, François A Leblond
1PRP-HOM, SRBE, laboratoire de radiotoxicologie expérimentale (LRTOX), Institut de radioprotection et de sureté nucléaire (IRSN), Fontenay-aux-Roses, France. yann.gueguen@irsn.fr
Abstract:
Over the last few decades, prevalence of renal diseases has grown continuously in occidental societies due to life conditions (age, life style, chronic disease, etc.) or potential exposure to nephrotoxic agents (drugs and environmental chemicals). Today, the knowledge of the nephropatology mechanism is improving. Nevertheless, considering it is a complex and multifunctional structure, the clinical strategy of this issue (prognostic, diagnostic or therapy) keeps posing a major challenge for clinicians mostly because classical markers are not sensitive enough and require hours before reaching significant levels. Furthermore, most of these markers provide information on function and not on structural integrity of the tissue. Identification and development of new biomarkers share promise of improvement in the rapid diagnostic of kidney diseases and development of new cures in order to optimize the clinical strategy associated to the renal failure.
Insights
The increasing prevalence of kidney diseases necessitates improved diagnostic tools. Developing novel biomarkers promises faster detection and better treatment strategies for renal failure.
Area of Science:
- Nephrology
- Biomarker Discovery
- Clinical Pathology
Context:
- Rising prevalence of renal diseases in Western societies linked to lifestyle and environmental factors.
- Current diagnostic markers for kidney disease are often slow, lack sensitivity, and primarily assess function over tissue integrity.
- Understanding nephropathology mechanisms is advancing, but clinical management remains challenging.
Purpose:
- To highlight the limitations of current kidney disease biomarkers.
- To emphasize the need for novel biomarkers for rapid diagnosis and improved therapeutic strategies.
- To address the challenges in clinical management of renal failure.
Summary:
- Kidney diseases are increasing due to lifestyle and environmental factors.
- Existing diagnostic markers for kidney disease are insufficient, providing delayed and incomplete information.
- New biomarkers are crucial for early detection, accurate prognosis, and effective treatment of renal failure.
Impact:
- Accelerated diagnosis of kidney diseases.
- Enhanced understanding of renal tissue integrity.
- Optimized clinical strategies for managing renal failure and improving patient outcomes.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Serum Studies: Renal Function Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...